Despite high expression of common BCP-ALL–associated proteins, such as CD19, CD34, and CD38, expression of others, including CD133, PAX5, and BCL2, was more heterogeneous (Supplemental Figure 2, B–D), indicating the phenotypic heterogeneity of (t;411) BCP-ALL. This evidence concerns the gene BCL2 and acute lymphoblastic leukemia.